Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

被引:0
|
作者
Ren Sun
Liya Wang
机构
[1] Swedish University of Agricultural Sciences,Department of Anatomy, Physiology, and Biochemistry
[2] The Biomedical Centre,undefined
来源
关键词
Growth inhibition; 6-thioguanine; Trifluorothymidine; Hypoxanthine guanine phosphoribosyl transferase; Thymidine kinase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [31] Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
    Jeon, Sangeun
    Ko, Meehyun
    Lee, Jihye
    Choi, Inhee
    Byun, Soo Young
    Park, Soonju
    Shum, David
    Kim, Seungtaek
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [32] Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro
    Bader, Ted
    Korba, Brent
    ANTIVIRAL RESEARCH, 2010, 86 (03) : 241 - 245
  • [33] Computational insights into VacA toxin inhibition: harnessing FDA-approved antibiotics against Helicobacter pylori
    Kashyap, Dharmendra
    Koirala, Suman
    Roy, Rajarshi
    Saini, Vaishali
    Varshney, Nidhi
    Bagde, Pranit Hemant
    Samanta, Sunanda
    Kar, Parimal
    Jha, Hem Chandra
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [34] Projected Growth in FDA-Approved Artificial Intelligence Products Given Venture Capital Funding
    McNabb, Nicole K.
    Christensen, Eric W.
    Rula, Elizabeth Y.
    Coombs, Laura
    Dreyer, Keith
    Wald, Christoph
    Treml, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2024, 21 (04) : 617 - 623
  • [35] Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
    Plaze, Marion
    Attali, David
    Prot, Matthieu
    Petit, Anne-Cecile
    Blatzer, Michael
    Vinckier, Fabien
    Levillayer, Laurine
    Chiaravalli, Jeanne
    Perin-Dureau, Florent
    Cachia, Arnaud
    Friedlander, Gerard
    Chretien, Fabrice
    Simon-Loriere, Etienne
    Gaillard, Raphael
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (03)
  • [36] FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
    Mostafa, Ahmed
    Kandeil, Ahmed
    Elshaier, Yaseen A. M. M.
    Kutkat, Omnia
    Moatasim, Yassmin
    Rashad, Adel A.
    Shehata, Mahmoud
    Gomaa, Mokhtar R.
    Mahrous, Noura
    Mahmoud, Sara H.
    GabAllah, Mohamed
    Abbas, Hisham
    El Taweel, Ahmed
    Kayed, Ahmed E.
    Kamel, Mina Nabil
    El Sayes, Mohamed
    Mahmoud, Dina B.
    El-Shesheny, Rabeh
    Kayali, Ghazi
    Ali, Mohamed A.
    PHARMACEUTICALS, 2020, 13 (12) : 1 - 24
  • [37] MEDI 321-Design and synthesis of carbocyclic nucleoside analogs as anticancer and antiviral drugs
    Sunkara, Naresh K.
    Seley, Katherine L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [38] Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
    Jungwirth, Gerhard
    Yu, Tao
    Liu, Fang
    Cao, Junguo
    Eddine, Montadar Alaa
    Moustafa, Mahmoud
    Abdollahi, Amir
    Warta, Rolf
    Unterberg, Andreas
    Herold-Mende, Christel
    CLINICAL CANCER RESEARCH, 2023, 29 (01) : 233 - 243
  • [39] Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
    Li, Xiang
    Li, Haitao
    Li, Shengqing
    Zhu, Feng
    Kim, Dong Joon
    Xie, Hua
    Li, Yan
    Nadas, Janos
    Oi, Naomi
    Zykova, Tatyana
    Yu, Dong Hoon
    Lee, Mee-Hyun
    Kim, Myoung Ok
    Wang, Lei
    Ma, Wei Ya
    Lubet, Ronald A.
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    CANCER RESEARCH, 2017, 77
  • [40] Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
    Li, Xiang
    Li, Haitao
    Li, Shengqing
    Zhu, Feng
    Kim, Dong Joon
    Xie, Hua
    Li, Yan
    Nadas, Janos
    Oi, Naomi
    Zykova, Tatyana A.
    Yu, Dong Hoon
    Lee, Mee-Hyun
    Kim, Myoung Ok
    Wang, Lei
    Ma, Weiya
    Lubet, Ronald A.
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    CARCINOGENESIS, 2012, 33 (12) : 2548 - 2557